| MESOR | midline estimating statistic of rhythm |
|---|---|
| NSR | nasal septal reconstruction; nonspecific reaction; normal sinus rhythm; no sign of recurrence; not s... |
| reg | rhy regular rhythm |
| R&R | rate and rhythm; rest and recuperation |
| RRR | regular rhythm and rate; renin release rate (or ratio) |
| HP-beta-CyD | 2-Hydroxypropyl-beta-cyclodextrin |
|---|---|
| HP-beta-CD | 2-hydroxy)propyl beta-cyclodextrin |
| 3 beta-HSD | 3 beta hydroxy steroid dehydrogenase |
| 3 beta-HSD | 3 beta-Hydroxysteroid dehydrogenase/isomerase |
| 3 beta-HSD | 3 beta-Hydroxysteroid dehydrogenasel delta 5-->4-isomerase |
| alpha-D-mannose-beta-1,2-N-acetylglucosaminyltransferase | <enzyme> Absolute specificity for terminal branched mannosyl residues of glycolipids Registry number: EC 2.4.1.- Synonym: udpgnac-1,2-magtransferase (26 Jun 1999) |
|---|---|
| amygdalin beta(1-6)glucosidase | <enzyme> Forms prunasin and glucose Registry number: EC 3.2.1.- Synonym: laetrile glucosidase, amygdalin hydrolase I, amygdalin hydrolase II (26 Jun 1999) |
| amyloid beta-protein | A 4 kD protein, 39-43 amino acids long, expressed by a gene located on chromosome 21. It is the major protein subunit of the vascular and plaque amyloid filaments in individuals with alzheimer's disease and in aged individuals with trisomy 21 (down syndrome). The protein is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. (12 Dec 1998) |
| amyloid beta-protein precursor | A precursor to the amyloid-beta protein (beta/a4). Alterations in the expression of the amyloid beta-protein precursor (abpp) gene, located on chromosome 21, plays a role in the development of the neuropathology common to both alzheimer disease and down syndrome. Abpp is associated with the extensive extracellular matrix secreted by neuronal cells. Upon cleavage, this precursor produces three proteins of varying amino acid lengths: 695, 751, and 770. The beta/a4 (695 amino acids) or beta-amyloid protein is the principal component of the extracellular amyloid in senile plaques found in alzheimer disease, down syndrome and, to a limited extent, in normal aging. (12 Dec 1998) |
| androst-16-en-3 beta-ol sulfotransferase | <enzyme> A beta sulfotransferase Registry number: EC 2.8.2.- Synonym: aebo sulfotransferase (26 Jun 1999) |
| androsta-5,16-dien-3 beta-ol synthetase | <enzyme> Nadph- and o(2)-dependent; converts progesterone to 4,16-androstadien-3-one and converts pregnenolone to androstadienol Registry number: EC 1.- Synonym: pregnenolone side-chain cleavage enzyme, 5,16-androstadien-3 beta-ol synthetase, 5,16-androstadien-3-ol synthase, 4,16-androstadien-3-one synthesizing enzyme, 4,16-adien-3-one synthase, 4,16-ado synthase, delta(16)-c(19)-steroid synthetase, andien-beta-synthetase, 16-ene-synthetase (26 Jun 1999) |
| beta | Entry pre fix is generally ignored for alphabetical reference, look for main portion of word. (18 Nov 1997) |
| beta (1)-anticollagenase | <chemical> A serum protein inhibitor (26 Jun 1999) |
| beta-(2-furyl)-acryloyl phosphate hydrolase | <enzyme> Used as synthetic substrate for atpase assay Registry number: EC 3.6.1.- Synonym: bfa phosphatase (26 Jun 1999) |
| beta 2-microglobulin | An 11 kD protein associated with the outer membrane of many cells including lymphocytes. It is the small subunit of the MHC class I molecule. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, csf, and urine of normal people, and to a much greater degree in the urine and plasma of patients with tubular proteinaemia, renal failure, or kidney transplants. (12 Dec 1998) |
| beta-adrenergic blocking agent | A class of drugs that compete with beta-adrenergic agonists for available receptor sites; some compete for both b1 and b2 receptors (e.g., propranolol) while others are primarily either b1 (e.g., metoprolol) or b2 blockers; used in the treatment of a variety of cardiovascular diseases where beta-adrenergic blockade is desirable. Synonym: beta-adrenergic receptor blocking agent, beta-adrenoreceptor antagonist, beta-blocker. (05 Mar 2000) |
| beta-adrenergic receptor blocking agent | A class of drugs that compete with beta-adrenergic agonists for available receptor sites; some compete for both b1 and b2 receptors (e.g., propranolol) while others are primarily either b1 (e.g., metoprolol) or b2 blockers; used in the treatment of a variety of cardiovascular diseases where beta-adrenergic blockade is desirable. Synonym: beta-adrenergic receptor blocking agent, beta-adrenoreceptor antagonist, beta-blocker. (05 Mar 2000) |
| beta-adrenergic receptor kinase | <enzyme> Cyclic-AMP protein kinase which specifically phosphorylates the agonist-occupied form of beta-adrenergic receptor Registry number: EC 2.7.1.- Synonym: beta-ar kinase, beta-adrenergic receptor kinase 1, g-protein-coupled receptor kinase 2, grk2 (kinase), beta-adrenergic receptor kinase 2, beta-ar kinase 2 (26 Jun 1999) |
| beta-adrenergic receptors | Adrenergic receptor's in effector tissues capable of selective activation and blockade by drugs; conceptually derived from the ability of certain agents, such as propranolol, to block only some adrenergic receptor's and of other agents, such as isoproterenol, to activate only the same adrenergic receptor's. Such receptor's are designated as beta-receptors. Their activation results in physiological responses such as increases in cardiac rate and force of contraction (b1), and relaxation of bronchial and vascular smooth muscle (b2). (05 Mar 2000) |
| beta-adrenoreceptor antagonist | A class of drugs that compete with beta-adrenergic agonists for available receptor sites; some compete for both b1 and b2 receptors (e.g., propranolol) while others are primarily either b1 (e.g., metoprolol) or b2 blockers; used in the treatment of a variety of cardiovascular diseases where beta-adrenergic blockade is desirable. Synonym: beta-adrenergic receptor blocking agent, beta-adrenoreceptor antagonist, beta-blocker. (05 Mar 2000) |